Natriuretic peptides (NPs) reduce central venous pressure in patients with chronic heart failure (cHF) despite attenuation of arterial, renal, and humoral effects. This suggests a preserved venodilator response. This study had 4 aims: to compare the venodilator effects of human NPs in patients with cHF; to assess the contribution of basal ANP and BNP levels to regulation of forearm vascular volume (FVV); to test the hypothesis that venous ANP responsiveness is preserved in cHF; and to assess the involvement of endothelial nitric oxide-synthase (eNOS) in NP-induced vascular effects.
|Number of pages||7|
|Journal||Arteriosclerosis, Thrombosis, and Vascular Biology|
|Publication status||Published - 2004|
Schmitt, M., Gunaruwan, P., Payne, N., Taylor, J., Lee, L., Broadley, A. J. M., Nightingale, A. K., Cockcroft, J. R., Struthers, A. D., Tyberg, J. V., & Frenneaux, M. P. (2004). Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(5), 911-7. https://doi.org/10.1161/01.ATV.zhq0504.7914